"We provide comprehensive cardiovascular diagnostic and therapeutic services to the residents of Santa Monica and greater Los Angeles. Our board-certified cardiologists with extensive subspecialty training and experience take pride in bringing the state-of-the-art technologies to treat patients. We consider the trusting relationship that develops between a patient and the doctor a valuable asset in achieving the common goal of wellness."

During the past decade, Pacific Heart Institute conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Heart Institute" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Boston Scientific Corporation" with 4 trials sponsored, "CardioFocus" with 2 trials sponsored, "Conformal Medical, Inc" with 2 trials sponsored and "Eidos Therapeutics, a BridgeBio company" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Heart Institute" #1 collaborator was "Applied Health Research Centre" with 1 trials as a collaborator and "Yale Cardiovascular Research Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Heart Institute" are "Atrial Fibrillation" (7 trials), "Stroke" (4 trials), "Bradycardia" (3 trials), "Cardiac Rhythm Disorder" (2 trials) and "Heart Disease" (2 trials). Many other conditions were trialed in "Pacific Heart Institute" in a lesser frequency.

Most popular intervention types in "Pacific Heart Institute" are "Device" (21 trials), "Drug" (8 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Guanfacine" (2 trials), "Warfarin" (2 trials), "Acoramidis (AG10)" (1 trials) and "Aegis Sierra Ligation System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Heart Institute" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Pacific Heart Institute". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 14 completed trials in Pacific Heart Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Heart Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".